SonoScape Medical Corp (300633) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SonoScape Medical Corp (300633) has a cash flow conversion efficiency ratio of -0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-130.62 Million ≈ $-19.11 Million USD) by net assets (CN¥3.12 Billion ≈ $456.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SonoScape Medical Corp - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how SonoScape Medical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300633 total liabilities for a breakdown of total debt and financial obligations.
SonoScape Medical Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SonoScape Medical Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FLEX LNG Ltd
NYSE:FLNG
|
0.040x |
|
Huludao Zinc Industry Co Ltd
SHE:000751
|
0.111x |
|
HuBei SanFeng Intelligent Conveying Equipment Co Ltd
SHE:300276
|
0.088x |
|
Zhejiang Southeast Space Frame Co Ltd
SHE:002135
|
-0.137x |
|
Greattown Holdings Ltd A
SHG:600094
|
0.014x |
|
Focus Technology Co Ltd
SHE:002315
|
0.075x |
|
Guangzhou Zhiguang Electric Co Ltd
SHE:002169
|
-0.008x |
|
CBIZ Inc
NYSE:CBZ
|
0.013x |
Annual Cash Flow Conversion Efficiency for SonoScape Medical Corp (2012–2024)
The table below shows the annual cash flow conversion efficiency of SonoScape Medical Corp from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 300633 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.11 Billion ≈ $454.83 Million |
CN¥306.66 Million ≈ $44.87 Million |
0.099x | -37.15% |
| 2023-12-31 | CN¥3.15 Billion ≈ $460.35 Million |
CN¥493.88 Million ≈ $72.27 Million |
0.157x | -9.12% |
| 2022-12-31 | CN¥2.74 Billion ≈ $400.92 Million |
CN¥473.26 Million ≈ $69.25 Million |
0.173x | +34.27% |
| 2021-12-31 | CN¥2.36 Billion ≈ $344.64 Million |
CN¥302.99 Million ≈ $44.34 Million |
0.129x | -36.18% |
| 2020-12-31 | CN¥1.34 Billion ≈ $196.81 Million |
CN¥271.13 Million ≈ $39.68 Million |
0.202x | +48.68% |
| 2019-12-31 | CN¥1.40 Billion ≈ $205.49 Million |
CN¥190.39 Million ≈ $27.86 Million |
0.136x | -23.93% |
| 2018-12-31 | CN¥1.31 Billion ≈ $191.84 Million |
CN¥233.65 Million ≈ $34.19 Million |
0.178x | +38.62% |
| 2017-12-31 | CN¥1.06 Billion ≈ $155.02 Million |
CN¥136.21 Million ≈ $19.93 Million |
0.129x | -32.61% |
| 2016-12-31 | CN¥720.11 Million ≈ $105.38 Million |
CN¥137.38 Million ≈ $20.10 Million |
0.191x | +91.91% |
| 2015-12-31 | CN¥566.21 Million ≈ $82.85 Million |
CN¥56.29 Million ≈ $8.24 Million |
0.099x | -61.06% |
| 2014-12-31 | CN¥444.81 Million ≈ $65.09 Million |
CN¥113.55 Million ≈ $16.62 Million |
0.255x | +3.61% |
| 2013-12-31 | CN¥365.08 Million ≈ $53.42 Million |
CN¥89.94 Million ≈ $13.16 Million |
0.246x | +459.62% |
| 2012-12-31 | CN¥351.82 Million ≈ $51.48 Million |
CN¥15.49 Million ≈ $2.27 Million |
0.044x | -- |
About SonoScape Medical Corp
SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. The company offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image process… Read more